132 related articles for article (PubMed ID: 15524494)
1. Use and cost of antiretrovirals in France 1995-2000: an analysis based on the Medical Dossier on Human Immunodeficiency (release 2) database.
Flori YA; le Vaillant M
Pharmacoeconomics; 2004; 22(16):1061-70. PubMed ID: 15524494
[TBL] [Abstract][Full Text] [Related]
2. Association between prescription cost sharing and adherence to initial combination antiretroviral therapy in commercially insured antiretroviral-naïve patients with HIV.
Johnston SS; Juday T; Seekins D; Espindle D; Chu BC
J Manag Care Pharm; 2012 Mar; 18(2):129-45. PubMed ID: 22380472
[TBL] [Abstract][Full Text] [Related]
3. Utilization and costs of HIV antiretroviral drugs in Europe during the last ten years: Impact of generic antiretroviral drugs on cost reduction.
Rwagitinywa J; Sommet A; Palmaro A; Montastruc JL; Lapeyre-Mestre M
Health Policy; 2018 Mar; 122(3):237-242. PubMed ID: 29398158
[TBL] [Abstract][Full Text] [Related]
4. [Cost of Illness of HIV Patients under Anteretroviral Therapy in Germany - Results of the 48-Week Interim Analysis of the Prospective Multicentre Observational Study 'CORSAR'].
Kuhlmann A; Mittendorf T; Hower M; Heiken H; Gerschmann S; Klauke S; Lutz T; Bogner J; Degen O; van Lunzen J; Bachmann C; Stellbrink HJ; Schmidt W; Leistner I; Mahlich J; Ranneberg B; Stoll M
Gesundheitswesen; 2015 Jun; 77(6):e133-42. PubMed ID: 25247761
[TBL] [Abstract][Full Text] [Related]
5. [Management of patients with HIV infection: utilization of hospital structures and cost].
Bez G
Cah Sociol Demogr Med; 1989; 29(2):107-35. PubMed ID: 2790567
[TBL] [Abstract][Full Text] [Related]
6. Costs of intermittent versus continuous antiretroviral therapy in patients with controlled HIV infection: a substudy of the ANRS 106 Window Trial.
Charreau I; Jeanblanc G; Tangre P; Boyer L; Saouzanet M; Marchou B; Molina JM; Aboulker JP; Durand-Zaleski I;
J Acquir Immune Defic Syndr; 2008 Dec; 49(4):416-21. PubMed ID: 18931625
[TBL] [Abstract][Full Text] [Related]
7. Hospitalisation costs of metastatic melanoma in France; the MELISSA study (MELanoma In hoSpital coSts Assessment).
Fernandes J; Bregman B; Combemale P; Amaz C; de Léotoing L; Vainchtock A; Gaudin AF
BMC Health Serv Res; 2017 Aug; 17(1):542. PubMed ID: 28789648
[TBL] [Abstract][Full Text] [Related]
8. The lifetime cost of current human immunodeficiency virus care in the United States.
Schackman BR; Gebo KA; Walensky RP; Losina E; Muccio T; Sax PE; Weinstein MC; Seage GR; Moore RD; Freedberg KA
Med Care; 2006 Nov; 44(11):990-7. PubMed ID: 17063130
[TBL] [Abstract][Full Text] [Related]
9. Case fatality and health care costs in HIV-infected patients: evolution from 1992 to 2000 at Rouen University Hospital, France.
Basuyau F; Josset V; Merle V; Czernichow P
Int J STD AIDS; 2004 Oct; 15(10):679-84. PubMed ID: 15479505
[TBL] [Abstract][Full Text] [Related]
10. A comparative analysis of outpatient costs in HIV treatment programs.
Sarti FM; Nishijima M; Campino AC; Cyrillo DC
Rev Assoc Med Bras (1992); 2012; 58(5):561-7. PubMed ID: 23090227
[TBL] [Abstract][Full Text] [Related]
11. [Cost of multiple sclerosis in France].
Fromont A; Lehanneur MN; Rollot F; Weill A; Clerc L; Bonithon Kopp C; Binquet C; Moreau T
Rev Neurol (Paris); 2014; 170(6-7):432-9. PubMed ID: 24856285
[TBL] [Abstract][Full Text] [Related]
12. Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre.
Beck EJ; Mandalia S; Griffith R; Beecham J; Walters MD; Boulton M; Miller DL
Pharmacoeconomics; 2000 Jan; 17(1):53-69. PubMed ID: 10747765
[TBL] [Abstract][Full Text] [Related]
13. Direct costs for the treatment of HIV-infection in a German cohort after the introduction of HAART.
Stoll M; Claes C; Schulte E; Graf von der Schulenburg JM; Schmidt RE
Eur J Med Res; 2002 Nov; 7(11):463-71. PubMed ID: 12568973
[TBL] [Abstract][Full Text] [Related]
14. [Study on economic burden caused by antiretroviral treatment for people living with HIV/AIDS and influencing factors in Nanjing].
Zhang X; Li M; Feng Y; Bu K; Fu G; Liu X; Chen Y; Shi L; Bai C; Wei H; Huan X; Wang L
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 May; 36(5):440-4. PubMed ID: 26080630
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of antiretroviral treatment in two private medical centers in Addis, Ethiopia.
Habtegiorgis A; Gebreyesus S; Mulugeta E
Ethiop Med J; 2003 Oct; 41(4):345-51. PubMed ID: 15296416
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and cost effectiveness of early and late prevention of HIV/AIDS progression with antiretrovirals or antibiotics in Southern African adults.
Bachmann MO
AIDS Care; 2006 Feb; 18(2):109-20. PubMed ID: 16338768
[TBL] [Abstract][Full Text] [Related]
17. Healthcare utilization of patients accessing an African national treatment program.
Harling G; Orrell C; Wood R
BMC Health Serv Res; 2007 Jun; 7():80. PubMed ID: 17555564
[TBL] [Abstract][Full Text] [Related]
18. 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.
Sengupta S
N C Med J; 2008; 69(1):6-13. PubMed ID: 18429558
[TBL] [Abstract][Full Text] [Related]
19. Mean cost of a first combination antiretroviral therapy in HIV-infected patients in France, and determinants of expensive drugs prescription.
Colombie V; Pugliese-Wehrlen S; Deuffic-Burban S; Cuzin L; Pugliese P; Katlama C; Poizot-Martin I; Raffi F; Cabie A; Dellamonica P; Yazdanpanah Y;
Int J STD AIDS; 2012 Dec; 23(12):865-9. PubMed ID: 23258826
[TBL] [Abstract][Full Text] [Related]
20. The cost of HIV services at health facilities in Cambodia.
Thin K; Prum V; Johns B
PLoS One; 2019; 14(5):e0216774. PubMed ID: 31141514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
